Murat Yildirim, MD, PhD

Medical Affairs, H. Lundbeck A/S, Valby, Denmark

  • 3Articles
  • 16.6KReads
  • 2023–2026Active
  • 12Collaborators
  • 16Citations

About

Murat Yildirim, MD, PhD, is affiliated with Medical Affairs at H. Lundbeck A/S in Valby, Denmark. Yildirim has published research focused on schizophrenia and schizoaffective disorders, including studies on the effects and safety of antipsychotic treatments such as brexpiprazole and aripiprazole. The work encompasses analyses of treatment outcomes related to patient functioning, symptom management, and medication safety in clinical trial settings. Yildirim's publications span from 2023 to 2026 in Psychiatrist.com.

Publications

JCP
Effects of Brexpiprazole on Functioning in Patients with Schizophrenia Who Have Hostility and Agitation Symptoms
Original Research

Effects of Brexpiprazole on Functioning in Patients with Schizophrenia Who Have Hostility and Agitation Symptoms

July 20, 2026

This post hoc analysis showed that brexpiprazole may improve functioning in adults with schizophrenia, even if they have hostility and agitation symptoms.
, , , et al
JCP
NNT, NNH, and LLH for Aripiprazole Once-Monthly in Schizophrenia
Original Research

NNT, NNH, and LLH for Aripiprazole Once-Monthly in Schizophrenia

May 13, 2026

Data demonstrate a favorable benefit-risk profile for aripiprazole once-monthly 400 vs placebo in acute and maintenance treatment of schizophrenia.
, , , et al
JCP
Safety and Efficacy of Aripiprazole 2-Month Ready-to-Use 960 mg
Original Research

Safety and Efficacy of Aripiprazole 2-Month Ready-to-Use 960 mg

September 4, 2023

A new formulation of injectable aripiprazole for administration every 2 months showed similar rates of treatment-emergent adverse events to aripiprazole once-monthly 400 mg. Patients in both groups remained clinically...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe